We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$126B
Cap. Flow %
-18.88%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Technology 1.6%
2 Consumer Discretionary 1.3%
3 Financials 0.99%
4 Communication Services 0.86%
5 Healthcare 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAVE icon
12751
CALL
RAVE Restaurant Group
RAVE
$44.2M
$22K ﹤0.01%
21,600
-25,200
-54% -$31.1K
RKDA icon
12752
PUT
Arcadia Biosciences
RKDA
$1.24M
$22K ﹤0.01%
541
-17
-3% -$1.11K
XYLO
12753
DELISTED
Xylo Technologies
XYLO
$22K ﹤0.01%
+554
New +$28.9K
FINMW
12754
DELISTED
Marlin Technology Corporation Warrant
FINMW
$22K ﹤0.01%
31,798
OTRAW
12755
DELISTED
OTR Acquisition Corp. Warrant
OTRAW
$22K ﹤0.01%
+43,884
New +$24.4K
IGC icon
12756
CALL
IGC Pharma
IGC
$31.8M
$21K ﹤0.01%
21,400
-90,000
-81% -$121K
OLOX
12757
CALL
Olenox Industries
OLOX
$2.46M
$21K ﹤0.01%
2
-15
-88% -$244K
XNET
12758
CALL
Xunlei
XNET
$320M
$21K ﹤0.01%
10,500
-77,500
-88% -$203K
ASLN
12759
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$21K ﹤0.01%
470
-5,141
-92% -$308K
UFAB
12760
DELISTED
Unique Fabricating, Inc.
UFAB
$21K ﹤0.01%
+10,588
New +$27.7K
AXLA
12761
DELISTED
Axcella Health Inc. Common Stock
AXLA
$21K ﹤0.01%
+401
New +$28.1K
CTAQW
12762
DELISTED
Carney Technology Acquisition Corp. II Warrant
CTAQW
$21K ﹤0.01%
30,956
CEMI
12763
CALL
DELISTED
Chembio diagnostics, Inc.
CEMI
$21K ﹤0.01%
18,500
-119,200
-87% -$243K
LGHL
12764
PUT
Lion Group Holding
LGHL
$514K
0
LSTA icon
12765
Lisata Therapeutics
LSTA
$16.3M
$20K ﹤0.01%
1,578
-15,537
-91% -$240K
MSN icon
12766
Emerson Radio
MSN
$9.47M
$20K ﹤0.01%
+24,751
New +$25.8K
NNAVW
12767
DELISTED
NextNav Inc Warrant
NNAVW
$20K ﹤0.01%
+11,918
New +$18K
ABVEW
12768
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$20K ﹤0.01%
37,887
MKFG.WS
12769
DELISTED
Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share
MKFG.WS
$20K ﹤0.01%
+24,225
New +$29K
CPTK.WS
12770
DELISTED
Crown PropTech Acquisitions Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CPTK.WS
$20K ﹤0.01%
+35,211
New +$24.7K
PSTH.WS
12771
DELISTED
Pershing Square Tontine Holdings, Ltd. Warrants, exercisable for one share of Class A Common Stock f
PSTH.WS
$20K ﹤0.01%
15,048
AFI
12772
DELISTED
Armstrong Flooring, Inc.
AFI
$20K ﹤0.01%
+10,192
New +$24.6K
ZOM
12773
DELISTED
Zomedica Corp.
ZOM
$20K ﹤0.01%
65,158
-50,187
-44% -$22.6K
NAVB
12774
CALL
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$20K ﹤0.01%
20,100
-13,500
-40% -$19K
ENVB icon
12775
Enveric Biosciences
ENVB
$6.13M
$19K ﹤0.01%
+2
New +$28.1K

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass withdrew a net $126B in Q4 2021, closing 1,571 positions and reducing 6,197 holdings. Its most notable exit was Stamps.com, Inc., an estimated $78.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 1.9% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jeff Yass opened a new position in iShares Core MSCI Emerging Markets ETF worth $78.2M.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.